@prefix cas: <http://identifiers.org/cas/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix inchikey: <http://identifiers.org/inchikey/> .
@prefix massbank: <https://identifiers.org/massbank/> .
@prefix mbo: <http://www.massbank.jp/ontology/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix schema: <https://schema.org/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

massbank:MSBNK-BAFG-CSL2311094120 a mbo:MassSpectrum ;
    dcterms:creator "Kevin S. Jewell; Bj√∂rn Ehlig; Arne Wick" ;
    dcterms:date "2023-11-09"^^xsd:date ;
    dcterms:identifier "MSBNK-BAFG-CSL2311094120" ;
    dcterms:rights "Copyright 2023 Federal Institute of Hydrology, Koblenz, Germany under dl-de/by-2-0" ;
    mbo:analytical_methods_and_conditions [ a mbo:AnalyticalMethods ;
            mbo:ac_instrument "TripleTOF 5600 SCIEX" ;
            mbo:collision_energy "40" ;
            mbo:column_name "Zorbax Eclipse Plus C18 2.1 mm x 150 mm, 3.5 um, Agilent" ;
            mbo:flow_gradient "0 min min 98% A, 1 min 98% A, 2 min 80% A, 16.5 min 2% A, 22 min 2% A, 22.1 min 98% A, 27 min 98% A" ;
            mbo:flow_rate "0.3 mL/min" ;
            mbo:fragmentation_mode "CID" ;
            mbo:instrument_type "LC-ESI-QTOF" ;
            mbo:ion_mode "POSITIVE" ;
            mbo:ms_type "MS2" ;
            mbo:retention_time "7.064 min" ;
            mbo:solvent "A: Water 0.1% Formic acid, B: Acetonitrile 0.1% Formic acid" ] ;
    mbo:compound [ a schema:chemicalsubstance ;
            rdfs:label "Doxorubicin" ;
            mbo:ch_compound_class "Pharmaceutical" ;
            mbo:ch_exact_mass 5.431741e+02 ;
            rdfs:seeAlso cas:23214-92-8 ;
            schema:inChI "InChI=1S/C27H29NO11/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3/t10-,13-,15-,17-,22+,27-/m0/s1" ;
            schema:inChIKey inchikey:AOJJSUZBOXZQNB-TZSSRYMLSA-N ;
            schema:molecularFormula "C27H29NO11" ;
            schema:name "Doxorubicin" ;
            schema:smiles "C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](Cc3c2c(c4c(c3O)C(=O)c5cccc(c5C4=O)OC)O)(C(=O)CO)O)N)O" ] ;
    mbo:has_peak [ mbo:intensity 2.9e+00 ;
            mbo:mz 8.60615e+01 ;
            mbo:peak_sequential_number 1 ;
            mbo:relative_intensity 129 ],
        [ mbo:intensity 1.83e+01 ;
            mbo:mz 3.210744e+02 ;
            mbo:peak_sequential_number 10 ;
            mbo:relative_intensity 816 ],
        [ mbo:intensity 1.4e+00 ;
            mbo:mz 3.330751e+02 ;
            mbo:peak_sequential_number 11 ;
            mbo:relative_intensity 62 ],
        [ mbo:intensity 1.23e+01 ;
            mbo:mz 3.460463e+02 ;
            mbo:peak_sequential_number 12 ;
            mbo:relative_intensity 549 ],
        [ mbo:intensity 5e-01 ;
            mbo:mz 3.510851e+02 ;
            mbo:peak_sequential_number 13 ;
            mbo:relative_intensity 22 ],
        [ mbo:intensity 5e-01 ;
            mbo:mz 3.599344e+02 ;
            mbo:peak_sequential_number 14 ;
            mbo:relative_intensity 22 ],
        [ mbo:intensity 2.24e+01 ;
            mbo:mz 3.610695e+02 ;
            mbo:peak_sequential_number 15 ;
            mbo:relative_intensity 999 ],
        [ mbo:intensity 1e+00 ;
            mbo:mz 3.640558e+02 ;
            mbo:peak_sequential_number 16 ;
            mbo:relative_intensity 45 ],
        [ mbo:intensity 6.8e+00 ;
            mbo:mz 3.790802e+02 ;
            mbo:peak_sequential_number 17 ;
            mbo:relative_intensity 303 ],
        [ mbo:intensity 4.6e+00 ;
            mbo:mz 3.970889e+02 ;
            mbo:peak_sequential_number 18 ;
            mbo:relative_intensity 205 ],
        [ mbo:intensity 5e-01 ;
            mbo:mz 5.441666e+02 ;
            mbo:peak_sequential_number 19 ;
            mbo:relative_intensity 22 ],
        [ mbo:intensity 1e+00 ;
            mbo:mz 1.130606e+02 ;
            mbo:peak_sequential_number 2 ;
            mbo:relative_intensity 45 ],
        [ mbo:intensity 5e-01 ;
            mbo:mz 1.210643e+02 ;
            mbo:peak_sequential_number 3 ;
            mbo:relative_intensity 22 ],
        [ mbo:intensity 3.8e+00 ;
            mbo:mz 1.300867e+02 ;
            mbo:peak_sequential_number 4 ;
            mbo:relative_intensity 169 ],
        [ mbo:intensity 7e-01 ;
            mbo:mz 1.350423e+02 ;
            mbo:peak_sequential_number 5 ;
            mbo:relative_intensity 31 ],
        [ mbo:intensity 6e-01 ;
            mbo:mz 2.930811e+02 ;
            mbo:peak_sequential_number 6 ;
            mbo:relative_intensity 27 ],
        [ mbo:intensity 2.3e+00 ;
            mbo:mz 3.060543e+02 ;
            mbo:peak_sequential_number 7 ;
            mbo:relative_intensity 103 ],
        [ mbo:intensity 1.1e+00 ;
            mbo:mz 3.150647e+02 ;
            mbo:peak_sequential_number 8 ;
            mbo:relative_intensity 49 ],
        [ mbo:intensity 4e-01 ;
            mbo:mz 3.190777e+02 ;
            mbo:peak_sequential_number 9 ;
            mbo:relative_intensity 18 ] ;
    mbo:mass_spectram_meta_data [ a mbo:MassSpectramMetaData ;
            mbo:precursor_mz_value "544.1813"^^xsd:float ;
            mbo:precursor_type_value "[M+H]+" ] ;
    mbo:pk_num_peak 19 ;
    mbo:pk_splash "splash10-03ka-0009000000-f7912667a203e6910aa1" ;
    rdfs:comment "Acquisition method: 10.1002/rcm.8541" ;
    skos:definition "Doxorubicin; LC-ESI-QTOF; MS2; 40 V" .

